Fig. 3From: N6-methyladenosine (m6A) RNA methylation regulator SNRPC is a prognostic biomarker and is correlated with immunotherapy in hepatocellular carcinomaA Volcano map showing the low- and high-SNRPC groups. B Nineteen immune-related items enriched in the high- and low-SNRPC groups by GSVABack to article page